—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Dr. Reddy’s Laboratories Ltd ADR (RDY) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for RDY, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sector × region Health care in US: −2.1% week · −2.2% month · +3.3% quarter · +16.4% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
How it trades on rate days beta 0.61 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How RDY has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.61 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Dr. Reddy’s Laboratories Ltd ADR moved 0.61% on average · correlation 0.21 · higher than 63% of US names
  • Beta, last 3 months 0.57 about the same as over the year
  • On the 10 worst bond days −0.80% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.73% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - Specialty & Generic · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · US

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against RDY on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Dr. Reddy’s Laboratories Ltd ADR

RDY in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Dr. Reddy's Laboratories makes and sells prescription and over-the-counter medicines, running three segments: Global Generics for branded and generic finished drugs, PSAI for active pharmaceutical ingredients and contract research, and an Others unit developing oncology and inflammation therapies. It covers therapeutic areas from cardiovascular and diabetes to dermatology and pain management. The company is headquartered in Hyderabad, India, and lists in the US through American Depositary Shares.
Where it sits in the stack
Dr. Reddy's carries no seat in our index and sits outside the layers the diary maps for the AI build-out; it belongs instead to the diary's broader pharmaceutical coverage, tracked as a generics and active-ingredients manufacturer rather than as an infrastructure name.
Who it is priced against
Closelooknet's peer group is not set for this name; by industry it sits with other specialty and generic drug manufacturers, and the market names Teva Pharmaceutical Industries as a comparable generics maker.
Why Closelooknet tracks it
It carries a Closelooknet score, with the momentum module the one the diary flags, though the reading can shift nightly; it holds no index seat and no diary quotes so far.
What the diary watches
Whether the shares stabilise against their 50-day and 200-day averages after trading well off the 52-week high, which would change how the diary reads the momentum module.

Dr. Reddy’s Laboratories Ltd ADR (RDY) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 46/100 composite (momentum 29, quality 44, valuation 63) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 1.18%, semi-annual · last 0.0830 USD on 2026-07-24

Dividends and capital return

What RDY pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.15 USD per share · a 1.18% yield on the 2026-10-06 close 2 distributions, paid twice a year 2026-10-06
  • Change on the year +61.0% against the prior twelve months prior twelve months 0.0915 USD per share
  • Last distribution 0.0830 USD per share as the price series records it, within days of the ex-date 2026-07-24
  • By calendar year 2025: 0.0915 USD (partial) · 2026: 0.15 USD to date first distribution recorded in the three-year window: 2025-07-25
  • Dividends paid, FY2026 7.01 bn USD 35% of earnings
  • Buybacks, FY2026 none reported
  • Share count −0.1% in FY2026 326 m USD of stock-based compensation in the year
  • Capital returned 7.01 bn USD · 22% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Dr. Reddy’s Laboratories Ltd ADR (RDY)?

Dr. Reddy’s Laboratories Ltd ADR trades as RDY on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is RDY in a Closelooknet index?

Not currently — Dr. Reddy’s Laboratories Ltd ADR is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

What is Dr. Reddy’s Laboratories Ltd ADR's Closelooknet composite score?

46 out of 100, with momentum 29, quality 44 and valuation 63 sub-scores, as of 2026-10-07. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does RDY trade against its moving averages?

Recovery attempt under the 200-day: Trades +2.7% vs the 50-day and -5.2% vs the 200-day average, 19.5% below the 52-week high and +10.7% off the 52-week low. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Dr. Reddy’s Laboratories Ltd ADR compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic · US), Dr. Reddy’s Laboratories Ltd ADR (RDY) sits 19.5% below its 52-week high, 2.7% above its 50-day average; Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is 4.2% below, Teva Pharma Industries Ltd ADR (TEVA) is 4.1% below, Hims Hers Health Inc (HIMS) is 54.9% below. Put any of them next to RDY in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Dr. Reddy’s Laboratories Ltd ADR trade when bond yields rise?

Over the past year Dr. Reddy’s Laboratories Ltd ADR had a beta of 0.61 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 63% of US names. On the 10 sessions in which long bonds fell most it moved −0.80% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Dr. Reddy’s Laboratories Ltd ADR do?

Dr. Reddy's Laboratories makes and sells prescription and over-the-counter medicines, running three segments: Global Generics for branded and generic finished drugs, PSAI for active pharmaceutical ingredients and contract research, and an Others unit developing oncology and inflammation therapies. It covers therapeutic areas from cardiovascular and diabetes to dermatology and pain management. Closelooknet's peer group is not set for this name; by industry it sits with other specialty and generic drug manufacturers, and the market names Teva Pharmaceutical Industries as a comparable generics maker.

Where does Dr. Reddy’s Laboratories Ltd ADR sit in the AI build-out?

Dr. Reddy's carries no seat in our index and sits outside the layers the diary maps for the AI build-out; it belongs instead to the diary's broader pharmaceutical coverage, tracked as a generics and active-ingredients manufacturer rather than as an infrastructure name. It carries a Closelooknet score, with the momentum module the one the diary flags, though the reading can shift nightly; it holds no index seat and no diary quotes so far.

Does Dr. Reddy’s Laboratories Ltd ADR pay a dividend?

Dr. Reddy’s Laboratories Ltd ADR has paid 0.15 USD per share over the last twelve months, paid twice a year, a trailing yield of 1.18% on the 2026-10-06 close; the last distribution recorded in the price series was 0.0830 USD on 2026-07-24. In fiscal 2026 the company paid 7.01 bn USD in dividends, 22% of that year’s free cash flow. The share count fell 0.1% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for RDY, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.